Differential mast cell activation by transcriptomic signature analysis in the U-BIOPRED severe asthma cohort
A. TIOTIU (Nancy, France), Y. Badi (London, United Kingdom), N. Zounemat Kermani (London, United Kingdom), P. Hansbro (Newcastle, Australia), C. Wheelock (Stockholm, Sweden), S. Dahlen (Stockholm, Sweden), Y. Guo (London, United Kingdom), P. Sterk (Amsterdam, Netherlands), R. Djukanovic (Southampton, United Kingdom), I. Adcock (London, United Kingdom), F. Chung (London, United Kingdom)
Source: Virtual Congress 2020 – Novel methods, diagnostics and biomarkers of chronic lung diseases
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. TIOTIU (Nancy, France), Y. Badi (London, United Kingdom), N. Zounemat Kermani (London, United Kingdom), P. Hansbro (Newcastle, Australia), C. Wheelock (Stockholm, Sweden), S. Dahlen (Stockholm, Sweden), Y. Guo (London, United Kingdom), P. Sterk (Amsterdam, Netherlands), R. Djukanovic (Southampton, United Kingdom), I. Adcock (London, United Kingdom), F. Chung (London, United Kingdom). Differential mast cell activation by transcriptomic signature analysis in the U-BIOPRED severe asthma cohort. 3827
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: